Rocket Pharmaceuticals, Inc.
DE ˙ DB ˙ US77313F1066
2,44 € 0,00 (0,00%)
2026-06-04
DEL PRIS
SecurityDE:9IP1 / Rocket Pharmaceuticals, Inc.
InstitutionAdvisor Group Holdings, Inc.
Latest Disclosed Ownership1,592 shares
Latest Disclosed Value $ 5,699
Advisor Group Holdings, Inc. reports 1.18% decrease in ownership of 9IP1 / Rocket Pharmaceuticals, Inc.

On May 15, 2026 - Advisor Group Holdings, Inc. filed a 13F-HR form disclosing ownership of 1,592 shares of Rocket Pharmaceuticals, Inc. (DE:9IP1) valued at $4,481 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 1,611 shares of Rocket Pharmaceuticals, Inc.. This represents a change in shares of -1.18% during the quarter. The current value of the position is $3,884 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 1,592 -19 -1.18 6 0.00 0.0000
2026-02-17 2025-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 1,611 -1,437 -47.15 6 -44.44 0.0000
2025-11-14 2025-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 3,048 -365 -10.69 10 0.00 0.0000
2025-09-04 2025-06-30 13F/A-1 ROCKET PHARMACEUTICALS COM 77313F106 3,413 -221 -6.08 9 -62.50 0.0000
2025-08-13 2025-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 854 -2,780 9 0.0000
2025-05-12 2025-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 3,634 2,874 378.16 24 166.67 0.0001
2025-06-06 2024-12-31 13F/A-1 ROCKET PHARMACEUTICALS COM 77313F106 760 379 99.48 10 28.57 0.0000
2025-02-07 2024-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 151 -230 2 0.0000
2024-11-13 2024-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 381 -14 -3.54 7 -12.50 0.0000
2024-08-13 2024-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 395 139 54.30 9 33.33 0.0000
2024-05-10 2024-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 256 -2,276 -89.89 7 -92.00 0.0000
2024-02-12 2023-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 2,532 -221 -8.03 76 33.93 0.0001
2023-11-13 2023-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 2,753 504 22.41 56 27.27 0.0001
2023-08-21 2023-06-30 13F/A-1 ROCKET PHARMACEUTICALS COM 77313F106 2,249 250 12.51 45 29.41 0.0001
2023-08-10 2023-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 2,249 250 45 0.0000
2023-05-12 2023-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 1,999 76 3.95 34 -8.11 0.0001
2023-02-10 2022-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 1,923 1,723 861.50 38 1,133.33 0.0001
2022-11-14 2022-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 200 -45 -18.37 3 -25.00 0.0000
2022-08-10 2022-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 245 -42 -14.63 4 0.00 0.0000
2022-05-04 2022-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 287 -22 -7.12 4 -33.33 0.0000
2022-02-03 2021-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 309 33 11.96 6 -25.00 0.0000
2021-11-05 2021-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 276 0 0.00 8 -33.33 0.0000
2021-08-02 2021-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 276 -98 -26.20 12 -25.00 0.0000
2021-05-13 2021-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 374 143 61.90 16 23.08 0.0000
2021-02-10 2020-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 231 200 645.16 13 1,200.00 0.0000
2020-11-12 2020-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 31 0 0.00 1 0.00 0.0000
2020-08-14 2020-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 31 0 0.00 1 0.0000
2020-05-18 2020-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 31 31 0 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.